Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone metastases chemotherapy monitoring in breast cancer
- 1 March 1999
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 281 (1-2) , 77-88
- https://doi.org/10.1016/s0009-8981(98)00209-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- New biochemical markers of bone resorption in the study of postmenopausal osteoporosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1997
- Increased bone turnover in late postmenopausal women is a major determinant of osteoporosisJournal of Bone and Mineral Research, 1996
- Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretionJournal of Bone and Mineral Research, 1995
- Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessmentJournal of Clinical Endocrinology & Metabolism, 1995
- Recent advances in biochemical markers of bone turnoverClinical Chemistry, 1994
- Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone diseaseJournal of Clinical Endocrinology & Metabolism, 1994
- Increased urinary excretion of pyridinium cross-links in cancer patientsClinical Chemistry, 1993
- Urinary pyridinium cross-links as markers of bone resorption in tumor- associated hypercalcemiaJournal of Clinical Endocrinology & Metabolism, 1992
- Phosphatase isoenzymes as bone metastasis markers in prostatic carcinomaClinical Biochemistry, 1991
- Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseaseBone and Mineral, 1990